US HR709 | 2013-2014 | 113th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 5-2)
Status: Introduced on July 31 2014 - 25% progression, died in committee
Action: 2014-08-01 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Recognizes the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and ways those challenges can be addressed.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.

Sponsors


History

DateChamberAction
2014-08-01HouseReferred to the Subcommittee on Health.
2014-07-31HouseReferred to the House Committee on Energy and Commerce.

Subjects


US Congress State Sources


Bill Comments

feedback